Vetkalm en es it fr

Vetkalm Brand names, Vetkalm Analogs

Vetkalm Brand Names Mixture

  • No information avaliable

Vetkalm Chemical_Formula


Vetkalm RX_link

Vetkalm fda sheet

Vetkalm msds (material safety sheet)

Vetkalm MSDS

Vetkalm Synthesis Reference

No information avaliable

Vetkalm Molecular Weight

166.24 g/mol

Vetkalm Melting Point

No information avaliable

Vetkalm H2O Solubility

Appreciable as liquid hydrochloride salt

Vetkalm State


Vetkalm LogP


Vetkalm Dosage Forms

Liquid for injection

Vetkalm Indication

For the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease. It may also be used for evaluating emergency treatment in myasthenic crises.

Vetkalm Pharmacology

Edrophonium is a short and rapid-acting anticholinesterase drug. Its effect is manifest within 30 to 60 seconds after injection and lasts an average of 10 minutes. Edrophonium's pharmacologic action is due primarily to the inhibition or inactivation of acetylcholinesterase at sites of cholinergic transmission. Muscarinic receptors are found throughout the body, especially on muscle. Stimulation of these receptors causes to muscle contraction. In myasthenia gravis the body's immune system destroys many of the muscarinic receptors, so that the muscle becomes less responsive to nervous stimulation. Edrophonium chloride increases the amount of acetylcholine at the nerve endings. Increased levels of acetyl choline allow the remaining receptors to function more efficiently.

Vetkalm Absorption

Rapidly absorbed.

Vetkalm side effects and Toxicity

With drugs of this type, muscarine-like symptoms (nausea, vomiting, diarrhea, sweating, increased bronchial and salivary secretions and bradycardia) often appear with overdosage (cholinergic crisis).

Vetkalm Patient Information

No information avaliable

Vetkalm Organisms Affected

Humans and other mammals